Serveur d'exploration MERS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Emerging Developments on Pathogenicity, Molecular Virulence, Epidemiology and Clinical Symptoms of Current Middle East Respiratory Syndrome Coronavirus (MERS-CoV).

Identifieur interne : 002784 ( Ncbi/Curation ); précédent : 002783; suivant : 002785

Emerging Developments on Pathogenicity, Molecular Virulence, Epidemiology and Clinical Symptoms of Current Middle East Respiratory Syndrome Coronavirus (MERS-CoV).

Auteurs : Kannan Subbaram [Arabie saoudite] ; Hemalatha Kannan [Éthiopie] ; Mansour Khalil Gatasheh [Arabie saoudite]

Source :

RBID : pubmed:32288937

Abstract

Middle East respiratory syndrome coronavirus (MERS-CoV) is a recently reported virus that is associated with severe, life threatening and rapidly spreading primarily respiratory illness called the Middle East respiratory syndrome. MERS-CoV possesses a unique positive-sense single-stranded RNA and can undergo rapid mutation in the viral genome. This results in antigenic switching and genetic variation, finally leading to the emergence of novel and new MERS-CoV subtypes which are uncontrollable by vaccines. Researchers are also finding difficulties to sort out therapeutic intervention strategies for MERS-CoV. This virus can spread from human to human, but transmission from dromedary camels to humans plays a crucial epidemiological significance. Dromedary camel acts as "gene mixing vessels" for MERS-CoV and these virus particles undergo rapid change in them. Viral receptors called dipeptidyl peptidase-4 are important receptors for attachment and spread of MERS-CoV in humans. The current method of laboratory confirmation is through real-time polymerase chain reaction on bronchoalveolar lavage, sputum and tracheal aspirates. Unfortunately, till today there are no definite anti-viral drugs available for MERS-CoV.

DOI: 10.1016/j.hjb.2017.08.001
PubMed: 32288937

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:32288937

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Emerging Developments on Pathogenicity, Molecular Virulence, Epidemiology and Clinical Symptoms of Current Middle East Respiratory Syndrome Coronavirus (MERS-CoV).</title>
<author>
<name sortKey="Subbaram, Kannan" sort="Subbaram, Kannan" uniqKey="Subbaram K" first="Kannan" last="Subbaram">Kannan Subbaram</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Preparatory (Biology), Al-Ghad International Colleges for Applied Medical Sciences, Riyadh, Saudi Arabia.</nlm:affiliation>
<country xml:lang="fr">Arabie saoudite</country>
<wicri:regionArea>Department of Preparatory (Biology), Al-Ghad International Colleges for Applied Medical Sciences, Riyadh</wicri:regionArea>
<wicri:noRegion>Riyadh</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Kannan, Hemalatha" sort="Kannan, Hemalatha" uniqKey="Kannan H" first="Hemalatha" last="Kannan">Hemalatha Kannan</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Laboratory Sciences & Pathology, Jimma University, Ethiopia.</nlm:affiliation>
<country xml:lang="fr">Éthiopie</country>
<wicri:regionArea>Department of Laboratory Sciences & Pathology, Jimma University</wicri:regionArea>
<wicri:noRegion>Jimma University</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Khalil Gatasheh, Mansour" sort="Khalil Gatasheh, Mansour" uniqKey="Khalil Gatasheh M" first="Mansour" last="Khalil Gatasheh">Mansour Khalil Gatasheh</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Clinical Laboratory Sciences, Al-Ghad International Colleges for Applied Medical Sciences, Riyadh, Saudi Arabia.</nlm:affiliation>
<country xml:lang="fr">Arabie saoudite</country>
<wicri:regionArea>Department of Clinical Laboratory Sciences, Al-Ghad International Colleges for Applied Medical Sciences, Riyadh</wicri:regionArea>
<wicri:noRegion>Riyadh</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:32288937</idno>
<idno type="pmid">32288937</idno>
<idno type="doi">10.1016/j.hjb.2017.08.001</idno>
<idno type="wicri:Area/PubMed/Corpus">000D38</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000D38</idno>
<idno type="wicri:Area/PubMed/Curation">000D38</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000D38</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000D23</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000D23</idno>
<idno type="wicri:Area/Ncbi/Merge">002784</idno>
<idno type="wicri:Area/Ncbi/Curation">002784</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Emerging Developments on Pathogenicity, Molecular Virulence, Epidemiology and Clinical Symptoms of Current Middle East Respiratory Syndrome Coronavirus (MERS-CoV).</title>
<author>
<name sortKey="Subbaram, Kannan" sort="Subbaram, Kannan" uniqKey="Subbaram K" first="Kannan" last="Subbaram">Kannan Subbaram</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Preparatory (Biology), Al-Ghad International Colleges for Applied Medical Sciences, Riyadh, Saudi Arabia.</nlm:affiliation>
<country xml:lang="fr">Arabie saoudite</country>
<wicri:regionArea>Department of Preparatory (Biology), Al-Ghad International Colleges for Applied Medical Sciences, Riyadh</wicri:regionArea>
<wicri:noRegion>Riyadh</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Kannan, Hemalatha" sort="Kannan, Hemalatha" uniqKey="Kannan H" first="Hemalatha" last="Kannan">Hemalatha Kannan</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Laboratory Sciences & Pathology, Jimma University, Ethiopia.</nlm:affiliation>
<country xml:lang="fr">Éthiopie</country>
<wicri:regionArea>Department of Laboratory Sciences & Pathology, Jimma University</wicri:regionArea>
<wicri:noRegion>Jimma University</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Khalil Gatasheh, Mansour" sort="Khalil Gatasheh, Mansour" uniqKey="Khalil Gatasheh M" first="Mansour" last="Khalil Gatasheh">Mansour Khalil Gatasheh</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Clinical Laboratory Sciences, Al-Ghad International Colleges for Applied Medical Sciences, Riyadh, Saudi Arabia.</nlm:affiliation>
<country xml:lang="fr">Arabie saoudite</country>
<wicri:regionArea>Department of Clinical Laboratory Sciences, Al-Ghad International Colleges for Applied Medical Sciences, Riyadh</wicri:regionArea>
<wicri:noRegion>Riyadh</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Hayati : journal of biosciences</title>
<idno type="ISSN">1978-3019</idno>
<imprint>
<date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Middle East respiratory syndrome coronavirus (MERS-CoV) is a recently reported virus that is associated with severe, life threatening and rapidly spreading primarily respiratory illness called the Middle East respiratory syndrome. MERS-CoV possesses a unique positive-sense single-stranded RNA and can undergo rapid mutation in the viral genome. This results in antigenic switching and genetic variation, finally leading to the emergence of novel and new MERS-CoV subtypes which are uncontrollable by vaccines. Researchers are also finding difficulties to sort out therapeutic intervention strategies for MERS-CoV. This virus can spread from human to human, but transmission from dromedary camels to humans plays a crucial epidemiological significance. Dromedary camel acts as "gene mixing vessels" for MERS-CoV and these virus particles undergo rapid change in them. Viral receptors called dipeptidyl peptidase-4 are important receptors for attachment and spread of MERS-CoV in humans. The current method of laboratory confirmation is through real-time polymerase chain reaction on bronchoalveolar lavage, sputum and tracheal aspirates. Unfortunately, till today there are no definite anti-viral drugs available for MERS-CoV.</div>
</front>
</TEI>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002784 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 002784 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:32288937
   |texte=   Emerging Developments on Pathogenicity, Molecular Virulence, Epidemiology and Clinical Symptoms of Current Middle East Respiratory Syndrome Coronavirus (MERS-CoV).
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i   -Sk "pubmed:32288937" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a MersV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021